ANKRD1 and cardiac hypertrophy: One week after TAC, we noted that myocardial transduction of AAV-sh-Ankrd1 could inhibit cardiac hypertrophy evidenced by that the HW/BW ratio was significantly smaller in AAV-sh-Ankrd1-TAC mice than in the scramble-TAC mice (Fig. 5D).